UCB PHARMA LIMITED
Company Information
- Company Number
- 00209905
- Registered Address
- 208 Bath Road, Slough, Berkshire, SL1 3WE
- Status
- Active
- Employee Count
- 204
- Turnover
- £124,125,000
- EBITDA
- £10,251,000
Additional Details
- Website
- https://zirtek.co.uk/
- Company Type
- Private limited Company
- Incorporated On
- 24 November 1925
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Life Sciences And Medical Technology
- Region
- South East
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 29 Jul 2025 | 50 | 14% | 48% | 38% | 0% |
| 01 Jul 2024 - 31 Dec 2024 | 31 Jan 2025 | 48 | 17% | 44% | 39% | 8% |
| 01 Jan 2024 - 30 Jun 2024 | 16 Jul 2024 | 43 | 26% | 47% | 27% | 4% |
| 01 Jul 2023 - 31 Dec 2023 | 19 Jan 2024 | 49 | 24% | 47% | 29% | 7% |
| 01 Jan 2023 - 30 Jun 2023 | 08 Aug 2023 | 53 | 18% | 46% | 36% | 16% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 49 | 28% | 49% | 24% | 11% |
| 01 Jul 2020 - 31 Dec 2020 | 20 Jan 2021 | 51 | 23% | 50% | 27% | 9% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 34 | 44% | 34% | 21% | 34% |
| 01 Jan 2018 - 30 Jun 2018 | 25 Jul 2018 | 35 | 41% | 32% | 27% | 36% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
UCB payment terms are 60 days for most vendors. Some vendors are paid on 30 days term.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
Any complaints regarding payments, are to be logged with our accounts payable helpdesk. It will then be raised with the payments team and cause and resolution will be investigated. If there is any escalation it will be referred to the local accounts payable lead.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
UCB Pharma Limited is a global biopharmaceutical company that focuses on developing innovative treatments for patients with severe diseases. The company was founded in 1928 and is headquartered in Brussels, Belgium.
Sustainability is a key focus for UCB Pharma Limited, and they have implemented a sustainability program that aims to reduce their environmental impact, promote ethical and responsible business practices, and support the health and well-being of their employees and the communities they operate in. This includes initiatives such as reducing carbon emissions, promoting diversity and inclusion, and investing in research and development for sustainable healthcare solutions.
UCB Pharma Limited offers a range of products and services across several therapeutic areas, including central nervous system disorders, immunology, and bone disorders. Their portfolio includes both prescription medicines and consumer healthcare products, such as anti-epileptics, anti-inflammatory drugs, and vitamins.
The company's key people include CEO Jean-Christophe Tellier, who has been with UCB Pharma Limited since 2011 and has over 25 years of experience in the pharmaceutical industry. Other key executives include Head of Global Operations Iris Loew-Friedrich and Chief Medical Officer Dr. Dhavalkumar Patel.
Contact information for UCB Pharma Limited can be found on their website, including their registered office address in Brussels and a contact form for inquiries. Their website also provides information on their sustainability program, products and services, and company news and events.
